Volume 12, Number 3, March 2006

Medication Sales and Syndromic Surveillance, France

Elisabeta Vergu,*†‡ Rebecca F. Grais,*† Hélène Sarter,*† Jean-Paul Fagot,*† Bruno Lambert,§ Alain-Jacques Valleron,*†¶ and Antoine Flahault*†#
*Institut National de la Santé et de la Recherche Medicale Unité, Paris, France; †Université Pierre et Marie Curie, Paris, France; ‡Institut National de la Recherche Agronomique MIA, Jouy-en-Josas, France; §IMS FRANCE, Puteaux, France; ¶Hôpital Saint-Antoine, Paris, France; and #Hôpital Tenon, Paris, France

Figure 2. Model construction for national influenzalike illness (ILI) incidence forecasting 1, 2, and 3 weeks ahead for the training dataset (week 36 of year 2000 to week 38 of year 2003) by using a jackknife reestimation procedure (95% confidence intervals [CI] for estimations are given). Forecasted incidence is per 100,000.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed February 21, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention